Elevated cerebrospinal fluid levels of beta-2-microglobulin in patients with Guillain-Barre syndrome and their correlations with clinical features.
Liu MQ, Wang J, Huang CN, Qi Y, Zhang LJ, Yi M, Chang SH, Sun LS, Yang L.
Neurol Sci. 2021 Oct;42(10):4249-4255. doi: 10.1007/s10072-021-05108-2. Epub 2021 Feb 17.
PMID:33598798
Cerebrospinal fluid beta2-microglobulin as a diagnostic biomarker in central nervous system lymphoma: a single-center retrospective analysis.
Fan Y, Huang Y, Zheng W, Su Z, Hu J, Yuan S.
Ann Hematol. 2025 Nov;104(11):5711-5718. doi: 10.1007/s00277-025-06719-x. Epub 2025 Nov 10.
PMID:41212200
[Cerebrospinal Fluid beta2-Microglobulin for Prognostic Evaluation of Patients with Central Nervous System Infiltration in Acute Lymphoblastic Leukemia].
Yao ML, Chen TM, Li P.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Feb;30(1):113-118. doi: 10.19746/j.cnki.issn.1009-2137.2022.01.018.
PMID:35123612
Cerebrospinal fluid beta(2)-microglobulin in neuro-Behcet's syndrome.
Kawai M, Hirohata S.
J Neurol Sci. 2000 Oct 1;179(S 1-2):132-9. doi: 10.1016/s0022-510x(00)00403-2.
PMID:11054497
Elevated cerebrospinal fluid beta-2 microglobulin as a tumor marker in a patient with myeloma of the central nervous system.